🔗 Permalink

Assignee profile:

Avexxin AS

City:

Trondheim

Country:

Norway

Published Applications:

Last publication date:

2022-11-17

Patent Grants:

Last grant date:

2023-07-04

Top Inventors for applications by Avexxin AS

These are the the leading inventors for applications assigned to Avexxin AS:

Berit Johansen 20 Trondheim, Norway
Inger Reidun Aukrust 7 Oslo, Norway
George Kokotos 7 Athens, Greece
Astrid Jullumstro Feuerherm 6 Trondheim, Norway

Marcel Sanderberg 4 Oslo, Norway
Lars Skattebol 4 Oslo, Norway
Wenche Sjursen 4 Trondheim, Norway
Marit Anthonsen 4 Trondheim, Norway

Efrosini Barbayianni 3 Athens, Greece
Berit Johansen 3 Oslo, Norway
Anne Kristen Holmeide 3 Oslo, Norway
Andrea Huwiler 3 Bern, Switzerland

Marcel Sandberg 3 Oslo, Norway
Johan Evenäs 2 Lund, Sweden
Kildahl-Andersen Geir 2 Oslo, Norway
Michael Tsakos 2 Athens, Greece

Thomas Brimert 2 Lund, Sweden
Victoria Magrioti 2 Athens, Greece
Anne K. Holmeide 2 Oslo, Norway
Anders Ljungqvist 1 Trondheim, Norway

Michael Tsakos 1 , United States
Victoria Magrioti 1 , United States
Astrid Jullumistro Feuerherm 1 Trondheim, Norway
Philip Hansen 1 Hosrsholm, Denmark

Recent patent applications by Avexxin AS

Avexxin AS based in Trondheim, NO has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-11-17 ✅ Patent 11,691,959 granted on 2023-07-04

US20220363659A1

Chemistry; metallurgy

Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds

#2 | 2020-10-22

US20200330399A1

Human necessities

COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A CORTICOSTEROID

#3 | 2020-10-15

US20200323793A1

Human necessities

COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A CALCINEURIN INHIBITOR

#4 | 2020-09-24 ✅ Patent 11,034,666 granted on 2021-06-15

US20200299256A1

Chemistry; metallurgy

Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds

#5 | 2020-08-20 ✅ Patent 11,351,127 granted on 2022-06-07

US20200261378A1

Human necessities

Pharmaceutical composition

#6 | 2019-11-14 ✅ Patent 10,851,114 granted on 2020-12-01

US20190345168A1

Chemistry; metallurgy

2-oxothiatole compounds having activity as cPLAinhibitors for the treatment of inflammatory disorders and hyperproliferative disorders

#7 | 2019-09-12

US20190275010A1

Human necessities

COMBINATION THERAPY COMPRISING A THIAZOLE AND A SECOSTEROID TO TREAT SKIN CONDITIONS

#8 | 2019-06-06 ✅ Patent 10,758,499 granted on 2020-09-01

US20190167606A1

Human necessities

Dermatitis treatment

#9 | 2019-03-14 ✅ Patent 10,953,004 granted on 2021-03-23

US20190076423A1

Human necessities

Combination therapy for proliferative diseases

#10 | 2019-03-14 ✅ Patent 11,439,625 granted on 2022-09-13

US20190076407A1

Human necessities

Combination therapy for proliferative diseases

#11 | 2018-04-19 ✅ Patent 10,259,801 granted on 2019-04-16

US20180105507A1

Chemistry; metallurgy

Anti-inflammatory and antitumor 2-oxothiazoles ABD 2-oxothiophenes compounds

#12 | 2018-01-11 ✅ Patent 10,183,911 granted on 2019-01-22

US20180009745A1

Chemistry; metallurgy

Process for the preparation of a polyunsaturated ketone compound

#13 | 2017-06-15 ✅ Patent 10,150,781 granted on 2018-12-11

US20170166589A1

Chemistry; metallurgy

2-oxothiatole compounds having activity as CPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disorders

#14 | 2017-06-15 ✅ Patent 10,370,344 granted on 2019-08-06

US20170166539A1

Chemistry; metallurgy

2-oxothiazole compounds and method of using same for chronic inflammatory disorders

#15 | 2017-05-04 ✅ Patent 10,085,953 granted on 2018-10-02

US20170119694A1

Human necessities

Skin cancer treatment

#16 | 2016-06-09 ✅ Patent 10,093,618 granted on 2018-10-09

US20160159737A1

Chemistry; metallurgy

Process for the preparation of a polyunsaturated ketone compound

#17 | 2015-10-15 ✅ Patent 10,085,952 granted on 2018-10-02

US20150290144A1

Human necessities

Dermatitis treatment

#18 | 2015-07-23 ✅ Patent 9,375,409 granted on 2016-06-28

US20150202165A1

Human necessities

Use of polyunsaturated ketones for the treatment of psoriasis

#19 | 2014-09-11 ✅ Patent 9,187,396 granted on 2015-11-17

US20140256824A1

Chemistry; metallurgy

Compositions and methods for the treatment of glomerulonephritis

#20 | 2013-12-05 ✅ Patent 8,865,768 granted on 2014-10-21

US20130324613A1

Human necessities

Use of polyunsaturated ketones for the treatment of psoriasis

#21 | 2013-09-19 ✅ Patent 9,682,930 granted on 2017-06-20

US20130245127A1

Chemistry; metallurgy

Rheumatoid arthritis treatment

#22 | 2012-05-31

US20120136066A1

Chemistry; metallurgy

Glomerulonephritis Treatment

#23 | 2011-06-09 ✅ Patent 9,597,318 granted on 2017-03-21

US20110136879A1

Chemistry; metallurgy

2-oxothiazole compounds and method of using same for chronic inflammatory disorders

#24 | 2010-12-09 ✅ Patent 8,796,251 granted on 2014-08-05

US20100311843A1

Chemistry; metallurgy

Compositions and methods for the treatment of glomerulonephritis

#25 | 2010-06-17 ✅ Patent 8,524,776 granted on 2013-09-03

US20100152293A1

Human necessities

Use of polyunsaturated ketones for the treatment of psoriasis

#26 | 2005-07-28 ✅ Patent 7,687,543 granted on 2010-03-30

US20050165116A1

Human necessities

Use of polyunsaturated ketones for the treatment of psoriasis

Also check out Avexxin AS's (Trondheim, Norway) applicant profile with 18 patent applications submitted.

AssigneeID:

39638 ⎘